Speaker illustration

Doctor Susan Hennessy

University of California at San Francisco, San Francisco (United States of America)

Member of:

European Society of Cardiology
Heart Failure Association

Cost-effectiveness of semaglutide for secondary prevention of cardiovascular disease in the United States

Event: ESC Congress 2024

Topic: Health Economics

Session: Disparities: insights into socioeconomic factors and cardiovascular health

Thumbnail